Reversible conformational change in the plasmodium falciparum circumsporozoite protein masks Its adhesion domains

Infection and Immunity

Volumn 83, Issue 10, 2015, Pages 3771-3780

  Herrera, Raul ^a   Anderson, Charles ^a   Kumar, Krishan ^a   Molina Cruz, Alvaro ^a   Nguyen, Vu ^a   Burkhardt, Martin ^a   Reiter, Karine ^a   Shimp, Richard ^a   Howard, Randall F ^b   Srinivasan, Prakash ^a   Nold, Michael J ^c   Ragheb, Daniel ^d   Shi, Lirong ^d   DeCotiis, Mark ^a   Aebig, Joan ^a   Lambert, Lynn ^a   Rausch, Kelly M ^a   Muratova, Olga ^a   Jin, Albert ^e   Reed, Steven G ^b   Sinnis, Photini ^d   Barillas Mury, Carolina ^a   Duffy, Patrick E ^a   MacDonald, Nicholas J ^a   Naruma, David L ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^c WATERS CORPORATION   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; MALARIA VACCINE; MONOCLONAL ANTIBODY; PROTEOHEPARAN SULFATE; RECOMBINANT CIRCUMSPOROZOITE PROTEIN VACCINE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOPHELES STEPHENSI; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELL SURFACE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINE RESPONSE; EXPRESSION VECTOR; FEMALE; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; LIVER CELL; MIDGUT; MOUSE; NANP REPEAT DOMAIN; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEOMICS; RABBIT MODEL; SALIVARY GLAND; SPOROZOITE; THROMBOSPONDIN LIKE TYPE I REPEAT DOMAIN; WESTERN BLOTTING; ANIMAL; ANOPHELES; CHEMISTRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; PARASITOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ANOPHELES; ANTIBODIES, PROTOZOAN; EPITOPES; HEPATOCYTES; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; SPOROZOITES;

EID: 84944463567     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02676-14     Document Type: Article

References (38)

1. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Menard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Menard D. 2014. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50-55. http://dx.doi.org/10.1038/nature12876.
2. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. N Engl J Med 336:86-91.
3. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, Mtoro A, Sykes A, Ahmed S, Urassa AM, Ali AM, Mwangoka G, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Tahita MC, Kabore W, Ouedraogo S, Sandrine Y, Guiguemde RT, Ouedraogo JB, Hamel MJ, Kariuki S, Odero C, et al. 2011. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N Engl J Med 365:1863-1875. http://dx.doi.org/10.1056/NEJMoa1102287.
4. Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Machevo S, Acacio S, Bulo H, Sigauque B, Macete E, Alonso P, Abdulla S, Salim N, Minja R, Mpina M, Ahmed S, Ali AM, Mtoro AT, Hamad AS, Mutani P, Tanner M, Tinto H, D'Alessandro U, Sorgho H, Valea I, Bihoun B, Guiraud I, Kabore B, Sombie O, Guiguemde RT, Ouedraogo JB, Hamel MJ, Kariuki S, Oneko M, Odero C, Otieno K, Awino N, McMorrow M, Muturi-Kioi V, Laserson KF, Slutsker L, et al. 2012. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N Engl J Med 367:2284-2295. http://dx.doi.org/10.1056/NEJMoa1208394.
5. Bongfen SE, Ntsama PM, Offner S, Smith T, Felger I, Tanner M, Alonso P, Nebie I, Romero JF, Silvie O, Torgler R, Corradin G. 2009. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine 27:328-335. http://dx.doi.org/10.1016/j.vaccine.2008.09.097.
6. Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse PJ, Burton DR, Sanders RW, Moore JP, Ward AB, Wilson IA. 2013. Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342: 1477-1483. http://dx.doi.org/10.1126/science.1245625.
7. Ringe RP, Sanders RW, Yasmeen A, Kim HJ, Lee JH, Cupo A, Korzun J, Derking R, van Montfort T, Julien JP, Wilson IA, Klasse PJ, Ward AB, Moore JP. 2013. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A 110:18256-18261. http://dx.doi.org/10.1073/pnas.1314351110.
8. Srinivasan P, Ekanem E, Diouf A, Tonkin ML, Miura K, Boulanger MJ, Long CA, Narum DL, Miller LH. 2014. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria. Proc Natl Acad Sci U S A 111:10311-10316. http://dx.doi.org/10.1073/pnas.1409928111.
9. Coppi A, Natarajan R, Pradel G, Bennett BL, James ER, Roggero MA, Corradin G, Persson C, Tewari R, Sinnis P. 2011. The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J Exp Med 208: 341-356. http://dx.doi.org/10.1084/jem.20101488.
10. Coppi A, Pinzon-Ortiz C, Hutter C, Sinnis P. 2005. The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J Exp Med 201:27-33. http://dx.doi.org/10.1084/jem.20040989.
11. Plassmeyer ML, Reiter K, Shimp RL, Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL. 2009. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem 284:26951-26963. http://dx.doi.org/10.1074/jbc. M109.013706.
12. Miura K, Orcutt AC, Muratova OV, Miller LH, Saul A, Long CA. 2008. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26:193-200. http://dx.doi.org/10.1016/j.vaccine.2007.10.064.
13. Ozaki LS, Gwadz RW, Godson GN. 1984. Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J Parasitol 70:831-833. http://dx.doi.org/10.2307/3281779.
14. Kennedy M, Fishbaugher ME, Vaughan AM, Patrapuvich R, Boonhok R, Yimamnuaychok N, Rezakhani N, Metzger P, Ponpuak M, Sattabongkot J, Kappe SH, Hume JC, Lindner SE. 2012. A rapid and scalable density gradient purification method for Plasmodium sporozoites. Malar J 11:421. http://dx.doi.org/10.1186/1475-2875-11-421.
15. Shimp RL, Jr, Rowe C, Reiter K, Chen B, Nguyen V, Aebig J, Rausch KM, Kumar K, Wu Y, Jin AJ, Jones DS, Narum DL. 2013. Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle. Vaccine 31:2954-2962. http://dx.doi.org/10.1016/j.vaccine.2013.04.034.
16. Ejigiri I, Ragheb DR, Pino P, Coppi A, Bennett BL, Soldati-Favre D, Sinnis P. 2012. Shedding of TRAP by a rhomboid protease from the malaria sporozoite surface is essential for gliding motility and sporozoite infectivity. PLoS Pathog 8:e1002725. http://dx.doi.org/10.1371/journal.ppat.1002725.
17. Coppi A, Cabinian M, Mirelman D, Sinnis P. 2006. Antimalarial activity of allicin, a biologically active compound from garlic cloves. Antimicrob Agents Chemother 50:1731-1737. http://dx.doi.org/10.1128/AAC.50.5.1731-1737.2006.
18. Pinzon-Ortiz C, Friedman J, Esko J, Sinnis P. 2001. The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for Plasmodium sporozoite attachment to target cells. J Biol Chem 276:26784-26791. http://dx.doi.org/10.1074/jbc. M104038200.
19. Lumsden JM, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, Klein J, Bertholet S, Vedvick TS, Reed SG, Sattabongkot J, Bennett JW, Polhemus ME, Ockenhouse CF, Howard RF, Yadava A. 2011. Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion. Infect Immun 79:3492-3500. http://dx.doi.org/10.1128/IAI.05257-11.
20. + T cell immunity and protection in mice. Infect Immun 81:789-800. http://dx.doi.org/10.1128/IAI.01108-12.
21. Rathore D, Hrstka SC, Sacci JB, Jr, De la Vega P, Linhardt RJ, Kumar S, McCutchan TF. 2003. Molecular mechanism of host specificity in Plasmodium falciparum infection: role of circumsporozoite protein. J Biol Chem 278:40905-40910. http://dx.doi.org/10.1074/jbc. M306250200.
22. Coppi A, Tewari R, Bishop JR, Bennett BL, Lawrence R, Esko JD, Billker O, Sinnis P. 2007. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe 2:316-327. http://dx.doi.org/10.1016/j.chom.2007.10.002.
23. Doud MB, Koksal AC, Mi LZ, Song G, Lu C, Springer TA. 2012. Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc Natl Acad Sci U S A 109:7817-7822. http://dx.doi.org/10.1073/pnas.1205737109.
24. Rathore D, Nagarkatti R, Jani D, Chattopadhyay R, de la Vega P, Kumar S, McCutchan TF. 2005. An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion. J Biol Chem 280:20524-20529. http://dx.doi.org/10.1074/jbc. M414254200.
25. Myung JM, Marshall P, Sinnis P. 2004. The Plasmodium circumsporozoite protein is involved in mosquito salivary gland invasion by sporozoites. Mol Biochem Parasitol 133:53-59. http://dx.doi.org/10.1016/j.molbiopara.2003.09.002.
26. Nardin EH, Nussenzweig V, Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y. 1982. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 156:20-30. http://dx.doi.org/10.1084/jem.156.1.20.
27. Santoro F, Cochrane AH, Nussenzweig V, Nardin EH, Nussenzweig RS, Gwadz RW, Ferreira A. 1983. Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. J Biol Chem 258:3341-3345.
28. Boulanger N, Matile H, Betschart B. 1988. Formation of the circumsporozoite protein of Plasmodium falciparum in Anopheles stephensi. Acta Trop 45:55-65.
29. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. 2006. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5:144-156.
30. Singh AP, Buscaglia CA, Wang Q, Levay A, Nussenzweig DR, Walker JR, Winzeler EA, Fujii H, Fontoura BM, Nussenzweig V. 2007. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131:492-504. http://dx.doi.org/10.1016/j.cell.2007.09.013.
31. Gonzalez-Ceron L, Rodriguez MH, Wirtz RA, Sina BJ, Palomeque OL, Nettel JA, Tsutsumi V. 1998. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface. Exp Parasitol 90:203-211. http://dx.doi.org/10.1006/expr.1998.4334.
32. Holder AA, Blackman MJ, Burghaus PA, Chappel JA, Ling IT, McCallum-Deighton N, Shai S. 1992. A malaria merozoite surface protein (MSP1)-structure, processing and function. Mem Inst Oswaldo Cruz 87(Suppl 3):S37-S42.
33. Remarque EJ, Faber BW, Kocken CH, Thomas AW. 2008. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol 24:74-84. http://dx.doi.org/10.1016/j.pt.2007.12.002.
34. Howard RF, Narum DL, Blackman M, Thurman J. 1998. Analysis of the processing of Plasmodium falciparum rhoptry-associated protein 1 and localization of Pr86 to schizont rhoptries and p67 to free merozoites. Mol Biochem Parasitol 92:111-122. http://dx.doi.org/10.1016/S0166-6851(97)00238-7.
35. Narum DL, Thomas AW. 1994. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 67:59-68. http://dx.doi.org/10.1016/0166-6851(94)90096-5.
36. Persson C, Oliveira GA, Sultan AA, Bhanot P, Nussenzweig V, Nardin E. 2002. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. J Immunol 169:6681-6685. http://dx.doi.org/10.4049/jimmunol.169.12.6681.
37. 2+ ions by a peptide from the repeat region of the Plasmodium falciparum circumsporozoite protein. Malar J 13:195. http://dx.doi.org/10.1186/1475-2875-13-195.
38. Espinosa DA, Gutierrez GM, Rojas-Lopez M, Noe AR, Shi L, Tse SW, Sinnis P, Zavala F. 11 March 2015. Proteolytic cleavage of the P. falciparum circumsporozoite protein is a target of protective antibodies. J Infect Dis http://dx.doi.org/10.1093/infdis/jiv154.